The Metformin-mediated (1) increase in the levels of ACE2 and (2) the phosphorylation of ACE2 subsequently regulates RAAS offering cardiopulmonary protection, stability to the pulmonary endothelium, and mitigates pulmonary hypertension [53,80]. The gene discussed is ACE2; the disease is pulmonary arterial hypertension.